Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities. - Magnani CF; Gaipa G; Lussana F; Belotti D; Gritti G; Napolitano S; Matera G; Cabiati B; Buracchi C; Borleri G; Fazio G; Zaninelli S; et al. (The Journal of clinical investigation, 2020)